跳至主要内容
临床试验/IRCT2014080218659N1
IRCT2014080218659N1已完成2 期

The effect of propolis tablet on glycemic control, lipid profile and insulin resistance in comparison with placebo in patients with type 2 diabetes mellitus

Vice Chancellor for Research, Yazd Shahid Sadoughi University of Medical Sciences0 个研究点目标入组 67 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
67

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 75 years(—)
性别
All

入选标准

  • patients with type 2 diabetes mellitus, diagnosed 5-10 years ago, under treatment with oral hypoglycemic agents.
  • Exclusion criteria: pregnancy, lactation, insulin therapy, any other diseases such as autoimmune, intestinal, liver, thyroid and cardiovascular diseases, vitamin and mineral supplementation, history of dermal or digestive hypersensitivity to propolis, any severe respiratory disease (such as asthma, chronic bronchitis), report of side effects of propolis tablets.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Yazd Shahid Sadoughi University of Medical Sciences

相似试验